OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Lonza Group AG/  CH0013841017  /

Cboe Europe BXE
1/23/2025  10:13:15 AM Chg. +2.30 Volume Bid10:13:42 AM Ask1/23/2025 Market Capitalization Dividend Y. P/E Ratio
583.50CHF +0.40% 2,534
Turnover: 1.47 mill.		 583.40Bid Size: 5 583.60Ask Size: 35 43.4 bill.CHF 0.69% 65.63
GlobeNewswire 4/4/2024 Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire 10/16/2023 Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire 9/7/2023 Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings
GlobeNewswire 11/2/2021 Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strate...
GlobeNewswire 9/8/2021 Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment o...
GlobeNewswire 4/14/2021 aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
GlobeNewswire 3/12/2021 Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
GlobeNewswire 1/12/2021 Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the...
GlobeNewswire 1/8/2021 Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
GlobeNewswire 12/23/2020 Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
GlobeNewswire 11/10/2020 Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal V...
GlobeNewswire 9/4/2020 Institutional Investor Research Publishes 2020 Europe Executive Team Rankings
GlobeNewswire 2/6/2020 Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic...
GlobeNewswire 2/4/2020 Amarantus Releases Letter to Shareholders
GlobeNewswire 1/30/2020 Amarantus Acquires Majority Interest in CBD Wellness Company Hempori
GlobeNewswire 1/2/2020 Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products
GlobeNewswire 12/9/2019 Amarantus to Present at 12th Annual LD Micro Main Event
GlobeNewswire 12/4/2019 Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined w...
GlobeNewswire 11/21/2019 Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorder...
GlobeNewswire 11/18/2019 Amarantus Provides Recapitalization Update to Shareholders
GlobeNewswire 11/14/2019 Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test...
GlobeNewswire 10/30/2019 Global Primary Cells Market Analysis, Trends, and Forecasts Report 2019
GlobeNewswire 10/29/2019 Worldwide Cell Based Assay & High Content Screening Market Forecasts to 2024 - Candidate Growth, Imm...
GlobeNewswire 10/24/2019 Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Org...
GlobeNewswire 10/17/2019 Mesoblast and Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast’s Potential First U...